IPO Profile

Barrier Therapeutics Inc.
600 College Road East, Suite 3200, Princeton, New Jersey 08540
Tel: 609-945-1200
Web: www.barriertherapeutics.com
Ticker: BTRX
Stock Exchange: Nasdaq
Shares Issued: 5,000,000.00
Price Offered: $15.00
Amount Raised: $75,000,000.00

Underwriters:
Morgan Stanley & Co.
Banc of America Securities
J.P. Morgan



Company Description:
We are a biopharmaceutical company focused on the discovery, development and commercialization of a portfolio of innovative pharmaceutical products to address major medical needs in the field of dermatology. We currently have multiple product candidates in clinical development, with four of these candidates in or entering Phase III clinical trials. We believe that there exists significant commercial opportunity for a company focused specifically on the treatment of dermatological diseases, given the relatively fragmented nature of the dermatology market and the clinical limitations of currently approved treatments. Finally, we believe that we will be able to effectively commercialize our products, if approved, using a focused, specialty sales force.